L’Oreal to Buy 10% Stake in Swiss Injectables Maker Galderma (2)

Aug. 5, 2024, 8:57 AM UTC

L’Oreal SA is buying a 10% stake in Galderma Group AG, a Swiss maker of injectable skin fillers, with the two agreeing to collaborate on new products to reduce the signs of aging.

The French beauty company is acquiring the holding from EQT-led Sunshine SwissCo AG, Abu Dhabi Investment Authority and Auba Investment Pte., L’Oreal said in a statement Monday.

The purchase price wasn’t disclosed, but based on Galderma’s market value the stake would be worth about 1.6 billion Swiss francs ($1.9 billion). The deal will be made at an “undisclosed premium,” Galderma said.

Shares of Galderma, whose ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.